Publications

  • Mayo Collaborative Services v. Prometheus Labs., Inc.: U.S. Supreme Court Finds Prometheus Method Claims Unpatentable as Laws of Nature

  • FDA Publishes Draft Guidelines for Biosimilar Product Development

  • Patent Reform: Changes to Reissues and the New Supplemental Examination Procedure

  • Tips on Controlling Intellectual Property Protection Costs: What Business Owners Need to Know
  • Patentability of Process Claims and Business Method Inventions with No “Machine or Transformation”
  • From Your Office to the Patent Office: Tips on Gathering and Identifying Patentable Employee Inventions

  • Patent Reform: Transitional Review of Business Method Patents Under AIA

  • Patent Reform: New Section 298 Will Preclude Patentees from Proving Willfulness or Inducement Through an Alleged Infringer's Failure to Obtain or Provide Evidence of an Opinion of Counsel

  • “First-Inventor-to-File” to Replace the Current “First-to-Invent” System

  • Leahy-Smith America Invents Act Ratchets Up Fees 10 Days After Enactment

  • Stanford v. Roche: Part II: The Supreme Court Has Spoken
  • Post-Issuance Options: The Benefits and Risks of Reexamination and Reissue
  • Obviousness of Pharmaceuticals - Patentability Over Known, Structurally Similar Compounds
  • Stanford v. Roche, the Bayh-Dole Act, and the Possibility of Unintended Consequences

  • Where (and Even When) Does KSR Belong in Obviousness Arguments?
  • Patent Data, Prior Art, and Operational Transparency at the USPTO
    • Dennis D. Crouch
  • While Not Right for Every Invention, Trade Secret Protection Has Its Appeal
  • Considerations for Software Patent Claims in the United States, Europe, and Canada

  • Free, But Not Without Risk: Open Source Licensing in the Wake of Jacobsen v. Katzer
  • A Survey of the Peer to Patent Pilot Project
    • Eric Hamp
  • Citation by IDS: So What if I Didn't?
  • The Federal Circuit Decides to Reconsider Inequitable Conduct

  • With Bilski Having Come and Gone, It's Time to Get Back to Work
  • A Critique of Bilski's Textual Analysis
  • Avoiding Abstract Claims by Broadly Defining the Problem
    • Dennis D. Crouch
  • Questions Surrounding a Shift to an "Abstract Idea" Test
  • Bilski v. Kappos: Effects on Biotechnology Patents
  • Viewpoints on Life After Bilski v. Kappos

  • Rule Changes to European Patent Practice
  • Trade Secret Basics: What Every Business Owner Needs to Know
  • Enablement: The Federal Circuit Raises the Bar (Again)

  • Patent Valuation: How to Reduce Vulnerability and Increase Value
  • Maintaining Confidentiality in Technology Transactions: New Problems with an Old Concept
  • Revisiting the Patent Eligibility of Genes

  • Shire LLC v. Sandoz Inc.: Issue Preclusion and Markman Decisions
  • It Only Took a Hundred Years: The Federal Circuit Finally Settles the Doctrine of Infringement of Product-By-Process Claims
    • Eric Hamp
  • Copyright Basics: What Every Business Owner Should Know

  • Gene Patenting after In re Kubin: The Sky is Not Falling
  • The ABC's of ® and ©: Taking Note of Notice
  • The USPTO's New Written Description Training Materials: Impact on Biotech

  • Tafas v. Doll

  • Of Machines and Metamorphoses - Process and Software Claims After In re Bilski
  • Navigating Inventorship in the Chemical Industry
  • News from the USPTO

  • Computer-Implemented Claims Limitations and 35 USC SS 112, paragraph 6
  • Practical Patent Tips: How to Conduct an Effective Inventor Interview
  • Where Does the USPTO Go after Tafas/GSK v. Dudas?

  • Follow-on Biologic Drugs and Patent Law: A Potential Disconnect?
  • Seagate: Reports of the Death of Opinions of Counsel Have Been Greatly Exaggerated
  • Patent Litigation Under a Future Biosimilars Act
  • It's Not Easy Selling Green

  • E-Discovery FAQ: Part 2: Litigating Today Under the New Electronic Discovery Amendments
  • Duty of Disclosure: Citation of Non-Patent References
  • Trademark Infringement by the Sale and Use of Search Engine Keywords

  • ESI: Electronically Stored Information PowerPoint

  • mbhb News: Welcome New Associates
  • Federal Circuit Further Limits Doctrine of Equivalents Under "Specific Exclusion" Principle
  • Avoiding Patent Owner Disputes
    • Raef M. Shaltout
  • USPTO Patent Prosecution Practice Rule Changes

  • Recent Trends in E-Discovery, Part II: Cost Shifting, Burden Shifting, and Immortal Documents
  • Find Out What You Have Been Missing with a Trademark Audit
  • Patent Reform Act of 2005: Recent Developments
  • Due Diligence in Patent Licensing Transactions

  • Legislative Update: Joint Research Agreements May Protect Patent Rights
  • The Primary Source for Claim Construction: Dictionary or Specification?
  • The Continued Confusion Over Written Description
  • Recent Trends in E-Discovery, Part I: New Local Rules and Recent Judicial Opinions

  • On Your Mark! . . . Get Set! . . .Know!: Marking Fundamentals
  • Drafting the Technology Game Plan Part 5: Domain Name Protection
  • The Intersection of Trade Secrets and Patent Law: The Prior User Rights Statute, 35 U.S.C. § 273, Part 2
  • Patent Validity Assessments: Your Guide to Avoiding the On-Sale Bar, Part 2

  • The Intersection of Trade Secrets and Patent Law: The Prior User Rights Statute, 35 U.S.C. § 273, Part I
  • Electronic Laboratory Notebooks: Improved Data Storage or Increased Burden?
  • Festo Extended: Honeywell v. Hamilton Sundstrand
  • Caveat Sender, Part 2: Unintentional Disclosure In Electronic Documents
    • Brian R. Harris

  • Drafting the Technology Game Plan, Part 4: Effective Trademark Searching
  • Patent Validity Assessments: Your Guide to Avoiding the On-Sale Bar
  • Caveat Sender: What Else Is Attached to Your E-Mail?
    • Brian R. Harris
  • The New Statutory Interference Bar: Should You Monitor Competitors' Published Patents?
  • Claim Construction 101: Unlocking the Meaning of Preambles

  • National Prejudice: Alive and Well in the WIPO World
  • Tools of the Trade: Scope of the Section 271(e)(1) Research Exemption
  • Festo and the Federal Circuit: The Exception to the Exception to the Exception . . .
  • Doha Revisited: WTO Endorses Parallel Compulsory Licensing
  • Drafting the Technology Game Plan, Part 3: Proper Inventorship Determinations

  • Drafting the Technology Game-Plan, Part 1: Patent Searches
  • "Reach Through" the Searle Decision . . .
  • . . . And Show Me the Chemistry
  • Drafting the Technology Game-Plan, Part 2: Opinions of Counsel
  • Festo: The Federal Circuit Hears Oral Argument
  • From Doha to Baghdad via DC: U.S. Pharmaceutical Policy in a Troubled World
Close
Generate a PDF of your page(s)
Clear
Close
Remove
Page has been queued
An error has occurred
Add
Added to queue
View
Confirm Delete All Message
No Items in Packet Message
To add a page, select Add. To view the package, select View.
false
http://www.mbhb.com/pubs/xpqPublicationResults.aspx?xpST=Snippets&pdf=yes
a[href='javascript:packetBuilderSingleClick(document.title);']